Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.
D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004917:Erythromycin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D013754:Tetracyclines / Q000009:adverse effects / Q000627:therapeutic use; D014640:Vancomycin / Q000009:adverse effects / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D013754:Tetracyclines; D004917:Erythromycin; D014640:Vancomycin